Evidence for an intensity-dependent interaction of NAT2 acetylation genotype and cigarette smoking in the Spanish bladder cancer study

International Journal of Epidemiology

Volumn 36, Issue 1, 2007, Pages 236-241

  Lubin, Jay H ^a   Kogevinas, Manolis ^b,c   Silverman, Debra ^a   Malats, Núria ^c   Garcia Closas, Montserrat ^a   Tardón, Adonina ^d   Hein, David W ^e   Garcia Closas, Reina ^f   Serra, Consol ^g,h   Dosemeci, Mustafa ^a   Carrato, Alfredo ⁱ   Rothman, Nathaniel ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c UNIVERSITY OF CRETE   (Greece)

^d UNIVERSITY OF OVIEDO   (Spain)

^e University of Louisville School of Medicine   (United States)

^f HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^g Department of Pediatrics   (Spain)

^h UNIVERSITAT POMPEU FABRA   (Spain)

ⁱ HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

Author keywords

Bladder neoplasms; Dose response; Interaction; Smoking

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE;

CANCER; CARCINOGEN; DOSE-RESPONSE RELATIONSHIP; ENZYME ACTIVITY; GENOTYPE; HEALTH RISK; SMOKING;

ACETYLATION; ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RESEARCH; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; GENE INTERACTION; GENETIC CODE; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; SPAIN;

ACETYLATION; ADULT; AGED; AGED, 80 AND OVER; ARYLAMINE N-ACETYLTRANSFERASE; GENOTYPE; HUMANS; LINEAR MODELS; MIDDLE AGED; PHENOTYPE; RISK ASSESSMENT; SMOKING; SPAIN; TOBACCO; TOBACCO SMOKE POLLUTION; URINARY BLADDER NEOPLASMS;

EURASIA; EUROPE; SOUTHERN EUROPE; SPAIN;

NICOTIANA TABACUM;

EID: 34447331985     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dym043     Document Type: Article

References (11)

1. Vineis P, Marinelli D, Autrup H, Brockmoller J, Cascorbi I, Daly AK et al. Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: A pooled analysis of genotype-based studies. Cancer Epidemiol Biomarkers Prev 2001;10:1249-52.
2. Garcia-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: Results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 2005;366:649-59.
3. Vineis P, Kogevinas M, Simonato L, Brennan P, Boffetta P. Levelling-off of the risk of lung and bladder cancer in heavy smokers: An analysis based on multicentric case-control studies and a metabolic interpretation. Mutat Res-Rev in Mutat Res 2000;463:103-10.
4. Lubin JH, Caporaso N. Cigarette smoking and lung cancer: Modeling total exposure and intensity. Cancer Epidemiol Biomarkers Prev 2006; 15:517-23.
5. Samanic C, Kogevinas M, Dosemeci M, Malats N, Real FX, Garcia-Closas M et al. Smoking and bladder cancer in Spain: Effects of tobacco type, timing, environmental tobacco smoke and gender. Cancer Epidemiol Biomarkers Prev 2006;15:1348-54.
6. Preston DL, Lubin JH, Pierce DA, McConney ME. Epicure User's Guide Seattle, Washington, USA: HiroSoft International Corporation, 2006.
7. Gu J, Liang D, Wang YF, Lu C, Wc XF. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians. Mutat Res-Genetic Toxicol Environ Mutagen 2005;581:97-104.
8. Babu SR, Lakshmi VM, Huang GFW, Zenser TV, Davis BB. Glucuronide conjugates of 4-aminobiphenyl and its N-hydroxy metabolites-pH stability and synthesis by human and dog liver. Biochem Pharmacol 1996;51 1679-85.
9. Green MD, King CD, Mojarrabi B, Mackenzie PI, Tephly TR. Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3. Drug Metab Dispos 1998;26 507-12.
10. Al Zoughool M, Talaska G. High-performance liquid chromatography method for determination of N-glucuronidation of 4-aminobiphenyl by mouse, rat, and human liver microsomes. Anal Biochem 2005;340 352-58.
11. Vineis P, Bartsch H, Caporaso N, Harrington AM, Kadlubar FF, Landi MT et al. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature 1994;369:154-56.